Multimodal deep learning model improves risk prediction for cervical cancer radiotherapy decisions

Standard concurrent chemoradiotherapy (CCRT) for cervical cancer achieves disease-free survival (DFS) in approximately 70% of patients with locally advanced disease; however, nearly 30% still experience recurrence or metastasis.

Facebook Comments